Giving What We Can

Neglected Tropical Diseases

The term ‘neglected tropical diseases’ (or NTDs) covers 15 diseases that have often been overlooked in the battle against poverty. The most prevalent are:

  • Soil-transmitted helminthiasis (STH)
  • Schistosomiasis
  • Lymphatic Filariasis (LF)
  • Onchocerciasis
  • Trachoma

The first four of these are caused by parasitic worms inside one's body, while Trachoma is bacterial.

The Diseases

 
 

Soil-transmitted Helminthiasis (STH)

STH results from infection by roundworm, whipworm, or hookworm. They are the most common infections in the world and affect the most deprived communities: roundworm infects over 1 billion people, whipworm infects 795 million, and hookworm infects 740 million.


Infection is caused by accidentally ingesting eggs from contaminated soil or by the larvae in the soil actively penetrating the skin. Soil-transmitted helminths produce a range of symptoms including diarrhoea, abdominal pain, general malaise, and weakness. They can affect working and learning capacities and impair physical growth. Hookworms cause chronic intestinal blood loss that results in anaemia.1

 
     
 
   
     
 
 

Schistosomiasis

Schistosomiasis is a parasitic disease caused by flatworms. Larval forms of the parasites, which are released by freshwater snails, penetrate the skin of people in the water. Symptoms include progressive damage to the bladder, ureters, and kidneys, as well as progressive enlargement of the liver and spleen, intestinal damage, and hypertension. 2

 
     
 
   
     
 
 

Lymphatic Filariasis (LF)

LF (which is commonly known as elephantiasis) is caused by thread-like worms known as filariae which are spread from human to human by mosquito bites. Once inside the skin, they migrate to the lymphatic system where they cause significant damage and produce millions of offspring. LF is most well known for causing a disfiguring swelling of the limbs or genitals, that often leads to disability and social isolation.3

 
     
 
   
     
 
 

Onchocerciasis

Onchocerciasis, or river blindness, is caused by a certain type of filarial worm. It is transmitted from human to human through the bites of infected blackflies. The larvae form nodules under the skin, where they mature to adult worms. After mating, each female adult worm can release up to 1,000 offspring per day. These move through the body, and when they die they cause a variety of conditions, including blindness, lesions, and intense itching.4

 
     
 
   
     
 
 

Trachoma

Trachoma is a bacterial infection. It spreads from person to person, especially where there are shortages of water, numerous flies, and crowded living conditions. Infection often begins during infancy or childhood and can become chronic. If left untreated, the infection eventually causes the eyelid to turn inwards, which in turn causes the eyelashes to rub on the eyeball, resulting in intense pain and scarring of the front of the eye. This ultimately leads to irreversible blindness, typically at between 30 and 40 years of age.5

 
     
 
   
     

Cost-Effectiveness

These conditions can each be treated/prevented by taking the appropriate medication every 6–24 months. Recently people have started using a combination of five drugs, known as the rapid impact package, which allows all of the above diseases to be treated at once.

Charities which focus on neglected tropical diseases often advertise their cost-effectiveness in terms of the amount of money it takes to distribute one drug treatment:

Organization Advertized cost per annual treatment
Schistosomiasis Control Initiative $0.50 (rapid impact package)
Global Network for Neglected Tropical Diseases $0.50 (rapid impact package)
Helen Keller International $0.50 (rapid impact package)
Carter Center $0.18 (schistosomiasis only)
Global Alliance for the Elimination of Lymphatic Filariasis $1.00 (LF only)

The DCP2 and WHO-CHOICE cost-effectiveness estimates are as follows:

In other words, according to the DCP2 reports, $100 would prevent a total of 30 Disability Adjusted Life Years due to soil-transmitted helminthic infections. This is a health gain that is roughly on a par with saving a life. $1,000 would thus produce health benefits on a par with saving 10 people’s lives.

The reason these figures differ is that DCP2 and WHO measure cost-effectiveness in DALYs, whereas the charities’ estimates are simply for the cost of distribution of the drug. Not everyone who takes the drug suffers from the conditions listed, and ridding someone of these diseases for one year does not amount to one DALY averted (unless they would have died immediately from that disease were it not for the treatment). At the moment we are uncertain exactly how effective the combined-treatment Rapid Impact Package is; we are working on the conservative assumption that it is at least as cost-effective as treatment for STHs alone.

Other Information

Why is this treatment so cost-effective?

There are many reasons why these treatments are so effective, including:

  • The drugs need only be given once a year, and treatment through the school years can offer life-long protection.
  • Often, the drugs are donated by pharmaceutical companies. They are also exceptionally cheap to buy at market rates.
  • The drugs keep for 4 years and do not require refridgeration, which makes distribution much easier.
  • The high proportion of people infected, the very low price of the drugs, and the fact that the drugs are safe to take even if one is not infected, combine to mean that everyone in an affected area can be given the drug. Thus there is no need for a potentially costly screening process.
  • There is considerable geographical overlap and coinfection of these diseases, so it is often possible to treat many of them with one package of four drugs.
  • Because these diseases have been neglected in the past, the easiest and most cost-effective interventions have still not been performed.

Having said this, there are some other considerations that must be taken into account:

  • First, in general these drug treatments provide smaller benefits to many people, rather than very large benefits to fewer people. This means that small changes in the disability-weighting assigned to the impairments caused by NTDs, or changes in estimates about how much damage these NTDs do, can have large effects on cost-effectiveness estimates. However, it seems that, if anything, the disability weightings given are underestimates, possibly by a factor of 20. 6
  •  
     

    Reference:

    6.

    Disease Control Priorities In Developing Countries (DCP2), Chapter 24, pp. 470–471.

    Julia L. Finkelstein et al, 2008. ‘Decision-Model Estimation of the Age-Specific Disability Weight for Schistosomiasis Japonica: A Systematic Review of the Literature’, PLoS Negl Trop Dis 2(3): e158. doi:10.1371/journal.pntd.0000158.

    Peter Hotez et al, 2006. ‘Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria’, PLoS Med 3(5): e102. doi:10.1371/journal.pmed.0030102.

     
         
  • Second, one might think that many small benefits don’t add up to a large benefit: one might think that 10 DALYs are worth more if they are all averted for one person (e.g. by curing them of blindness) rather than if they are spread across 100 people (e.g. by treating them for minor parasitic infections). However, there are two things that must be borne in mind. Firstly, the health experts and ethicists who developed the DALY system recommend that it be used to aggregate benefits in precisely this way. Secondly, one must be careful not to underestimate the suffering that NTDs cause, which can include severe disability, social ostracization, and death.

Why are NTDs so little-known?

There are several reasons why these conditions have received relatively little attention. For example:

  • Unlike HIV/AIDS and tuberculosis, they do not affect rich countries, and therefore do not receive as much publicity within those countries. This means that it is more difficult for people in rich countries to know about them, and to empathize with those who suffer from them. It also means that there is little research done on them, so the extent of the damage that they cause was not appreciated until very recently.
  • NTDs have lower mortality rates than HIV/AIDS, tuberculosis and malaria. It is easier to convey the importance of diseases that are more likely to cause death.

Are there side-effects?

All health interventions have side-effects, both good and bad. In the case of drug treatments for neglected tropical diseases, it seems that the positive side effects may be even larger than the direct benefits.

Positive side-effects:

Negative side-effects:

  • It is possible that the parasites may become resistant to drugs over time.13 However, it is not clear whether this is a major issue14 and the WHO are sufficiently aware of the problem that they are taking steps to maintain drug efficacy.15
 
   
     
 
 

Reference:

14.

Personal communication with Professor Alan Fenwick of Imperial College.

 
     
 
 

Reference:

15.

Lawrence D, 2008. ‘What’s in a name? Drug resistance in helminth parasites’, The Lancet Infectious Diseases, 8:536–536.

 
     

Conclusion

Charities which focus on STH, schistosomiasis, and LF are at the very top end of cost-effectiveness — about 100 times more effective than typical developing-world health interventions — and they produce important positive side-effects. For these reasons, we have no hesitation in recommending that donors give to charities which work in this area.

In particular, we recommend Schistomiasis Control Initiative (SCI). For more information about them, see our list of recommended charities.

If you are looking for more information on neglected tropical diseases, a good place to start is this article.